Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Tg Therapeutics, Inc.

NASDAQ: TGTX · Life Sciences · 2 alerts · CIK 1001316

Share price
$62.76Close, Nov 16
Market cap
$9.49B
Shares outstanding
151.15MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Tg Therapeutics, Inc. filings on SEC EDGAR ↗

4:34 PM ET 10-Q
Financial Results

Tg Therapeutics Q3 2026 Results: Net Income $55.5M, Down 85.8% YoY

TG Therapeutics is focused on the commercialization of BRIUMVI for relapsing forms of multiple sclerosis and the development of its subcutaneous formulation and azer-cel. The company has a history of losses but is utilizing its commercial infrastructure to expand market acceptance while managing significant debt obligations and clinical trial expenses.

Key figure
Net income $55.5M · -85.8% YoY
7:05 AM ET 8-K
Financial Results

Tg Therapeutics Financial Results

TG Therapeutics reported Q3 2026 total global revenue of $259.9 million, driven by $232.6 million in U.S. net product revenue for BRIUMVI. The company raised its full-year 2026 total revenue guidance to approximately $1 billion and highlighted positive Phase 3 data for a simplified BRIUMVI initiation regimen.

Term
Q3 2026

“With solid third-quarter performance and a strong fourth quarter anticipated, we are on track to exceed $1 billion in global revenue in 2026, less than four years after launching BRIUMVI.”

Michael S. Weiss, Chairman and Chief Executive Officer

“Our increased full-year revenue guidance reflects the continued strength of our commercial business, while the approximately $100 million of shares repurchased during the quarter underscores our confidence in TG's long-term value.”

Michael S. Weiss, Chairman and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.